• Cancer treatment reviews · May 2010

    Clinical management of myeloma--state of the art.

    • Jean-Luc Harousseau.
    • Centre René Gauducheau, Nantes St Herblain, France. jl-harousseau@nantes.fnclcc.fr
    • Cancer Treat. Rev. 2010 May 1; 36 Suppl 2: S1-2.

    AbstractIn the last decade, advances in our understanding of the biology of myeloma have led to new treatment approaches that have resulted in unprecedented improvements in survival outcomes. These gains can be attributed in part to the introduction of three new active agents for the treatment of myeloma: thalidomide, lenalidomide, and bortezomib. With these treatments, however, have come new questions regarding the optimal approach to therapy, expected outcomes, and safety issues. In the articles included in this supplement, experts at the forefront of myeloma research provide insight into the management of patients with myeloma, and the current issues that clinicians face today regarding the best use of these agents.Copyright 2010 Elsevier Ltd. All rights reserved.

      Pubmed     Full text   Copy Citation     Plaintext  

      Add institutional full text...

    Notes

     
    Knowledge, pearl, summary or comment to share?
    300 characters remaining
    help        
    You can also include formatting, links, images and footnotes in your notes
    • Simple formatting can be added to notes, such as *italics*, _underline_ or **bold**.
    • Superscript can be denoted by <sup>text</sup> and subscript <sub>text</sub>.
    • Numbered or bulleted lists can be created using either numbered lines 1. 2. 3., hyphens - or asterisks *.
    • Links can be included with: [my link to pubmed](http://pubmed.com)
    • Images can be included with: ![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
    • For footnotes use [^1](This is a footnote.) inline.
    • Or use an inline reference [^1] to refer to a longer footnote elseweher in the document [^1]: This is a long footnote..

    hide…